Targeting YTHDF2 is a critical determiner for THM-induced autophagic cell death and the immunosensitizing effect of THM with anti-PD-1 inhibitor in pancreatic cancer. This evidence concerns the gene YTHDF2 and familial pancreatic carcinoma.